BCL2L1 - BCL2 like 1 Gene

Species: Macaca fascicularis

Gene Type: protein coding
Gene ID: 102140222

About BCL2L1

Primary_assembly 10: 64,282,480-64,344,052 reverse strand.Macaca_fascicularis_6.0:CM021948.1

This gene has 2 transcripts (splice variants), 285 orthologues and 5 paralogues.

BCL2L1 Products (11)

mRNA Protein Name
XM_005568630.3 XP_005568687.1 bcl-2-like protein 1 isoform X1
XM_015457887.2 XP_015313373.1 bcl-2-like protein 1 isoform X1
XM_005568629.3 XP_005568686.1 bcl-2-like protein 1 isoform X1
XM_045362708.1 XP_045218643.1 bcl-2-like protein 1 isoform X1
XM_005568633.3 XP_005568690.1 bcl-2-like protein 1 isoform X1
XM_005568637.3 XP_005568694.1 bcl-2-like protein 1 isoform X2
XM_005568632.3 XP_005568689.1 bcl-2-like protein 1 isoform X1
XM_015457885.2 XP_015313371.1 bcl-2-like protein 1 isoform X1
XM_005568634.3 XP_005568691.1 bcl-2-like protein 1 isoform X1
XM_015457886.2 XP_015313372.1 bcl-2-like protein 1 isoform X1
XM_005568631.3 XP_005568688.1 bcl-2-like protein 1 isoform X1

BCL2L1 Protein Structure

bcl-2

bcl-2: TIGR00865 (0 - 232)

  • 0
  • 100
  • 200
  • 233 a.a.
Protein Preferred Names Protein Names

bcl-2-like protein 1

Related Agents

  • Approval
  • Clinical Phase
  • Pre-clinical Phase

Approval

Bioactive Molecules (1)
Cat. No. Product Name Effect
Purity Rare Diseases
HY-B0420A Moroxydine hydrochloride Inhibitor 99.36% Unkown

Clinical Phase

Bioactive Molecules (5)
Cat. No. Product Name Effect
Purity Phase
HY-N1423 Glycocholic acid 99.90% Phase 3
HY-10969 Obatoclax Mesylate 99.85% Phase 3
HY-10969A Obatoclax ≥99.0% Phase 3
HY-15464 (R)-(-)-Gossypol 99.37% Phase 2
HY-15464A (R)-(-)-Gossypol acetic acid 98.93% Phase 2

Pre-clinical Phase

Bioactive Molecules (44)
Cat. No. Product Name
Effect
Purity
Rare Diseases
HY-N1423A Glycocholic acid sodium 97.0% Unkown
HY-N1423S Glycocholic acid-d4 99.92% Unkown
HY-125876 PROTAC Bcl2 degrader-1 Inhibitor 99.80% Unkown
HY-153803 GBD-9 Degrader 99.91% Unkown
HY-W013105 Sodium glycocholate hydrate, 98% 99.91% Unkown
HY-132307 Mcl-1 inhibitor 6 98.77% Unkown
HY-N1423B Glycocholic acid hydrate 99.85% Unkown
HY-135273 A-1211212 98.43% Unkown
HY-19551 Apogossypolone 98.58% Unkown
HY-N1423S1 Glycocholic acid-d5 99.9% Unkown
HY-15191B (S)-Sabutoclax Inhibitor 98.03% Unkown
HY-RS01421 BCL2L1 Human Pre-designed siRNA Set A / Unkown
HY-114310 VDR agonist 1 / Unkown
HY-123715 Anticancer agent 255 / Unkown
HY-144428 Bcl-2/Mcl-1-IN-2 Inhibitor / Unkown
HY-144430 Bcl-2/Mcl-1-IN-1 Inhibitor / Unkown
HY-144431 Bcl-2/Mcl-1-IN-3 Inhibitor / Unkown
HY-147826 EGFR-IN-60 / Unkown
HY-149436 CDK2/Bcl2-IN-1 Inhibitor / Unkown
HY-149681 Beclin1-Bcl-2 interaction inhibitor 1 Inhibitor / Unkown
HY-159513 Bcl-2/Mcl-1-IN-4 Inhibitor / Unkown
HY-161415 BCL-xL/BCL-2 ligand 1 / Unkown
HY-169083 Bcl-2-IN-22 Inhibitor / Unkown
HY-174338 GPER/Bcl-2-IN-1 Inhibitor / Unkown
HY-174403 c-MYC/BCL2 ligand 1 iodide / Unkown
HY-174404 Topoisomerase II inhibitor 23 / Unkown
HY-178910 Mcl-1-IN-20 / Unkown
HY-180371 NF-115 Inducer / Unkown
HY-181746 Bcl-2/Mcl-1-IN-5 / Unkown
HY-183369 VEGFR/PD-L1-IN-1 / Unkown
HY-N20627 Withametelin B / Unkown
HY-N3828 epi-Eriocalyxin A / Unkown
HY-RS01418 BCL2A1 Human Pre-designed siRNA Set A / Unkown
HY-RS01419 Bcl2a1 Rat Pre-designed siRNA Set A / Unkown
HY-RS01420 Bcl2a1a Mouse Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS01422 Bcl2l1 Mouse Pre-designed siRNA Set A / Unkown
HY-RS01423 Bcl2l1 Rat Pre-designed siRNA Set A / Unkown
HY-W016937 Moroxydine Inhibitor / Unkown
HY-W713297 Moroxydine hydrochloride-d8 Inhibitor / Unkown
HY-W754548 Glycocholic acid-13C2,d4 / Unkown
HY-12011A (Rac)-HA14-1 Inhibitor / Unkown
HY-174635 Human IL15RA mRNA / Unkown
HY-N6926 1,3,5-Tricaffeoylquinic acid / Unkown
HY-N8579 Eugenyl benzoate ≥90.0% Unkown

Orthologs Information

Species Symbol Source ID
Homo sapiens BCL2L1 NCBI NCBI:598